Macrogenics (NASDAQ:MGNX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Macrogenics missed estimated earnings by 235.56%, reporting an EPS of $-0.61 versus an estimate of $0.45.
Revenue was up $13.39 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 10.25% increase in the share price the next day.
Here’s a look at Macrogenics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.10 | -0.38 | -0.97 | -0.86 |
| EPS Actual | 0.21 | -0.40 | -0.67 | -1.08 |
| Revenue Estimate | 58.78M | 33.83M | 13.77M | 21.48M |
| Revenue Actual | 73.10M | 41.73M | 26.01M | 11.10M |
To track all earnings releases for Macrogenics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
